JNJ vs PODD
By Alex · Tickerpine
Johnson & Johnson vs Insulet Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | PODD |
|---|---|---|
| Price | $254.66 | $158.25 |
| Market cap | $613.02B | $10.96B |
| P/E ratio | 29.5 | 36.9 |
| ROE | 26.42% | 23.00% |
| Profit margin | 21.83% | 10.44% |
| Revenue growth | 9.90% | 33.90% |
| Dividend yield | 2.10% | — |
| Beta | 0.26 | 1.12 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs PODD in plain English
- JNJ is the bigger company — about 55.9× the market cap of PODD.
- JNJ is cheaper on earnings (P/E 29.5 vs 36.9).
- JNJ earns a higher return on equity (26% vs 23%).
- PODD is growing revenue faster (34% vs 10%).
- JNJ pays a dividend (2.10%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
PODD return calculator
See what $1,000 in Insulet Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.